| |
Where customer experience is our priority. Together with Fortrea –exceptional is possible. Experience Agility.
|
|
Today’s Big NewsDec 18, 2023 |
|
Slope's white paper reveals a breakthrough solution: software-guided sample workflows that ensure site compliance and keep your studies on track. Read more.
|
|
| By Max Bayer Biotech investors are licking their wounds after a year that's likely to have the lowest level of new fundraising in four years. Will 2024 finally be the rebound year? |
|
|
|
By Gabrielle Masson The Novo Nordisk Foundation is dedicating up to $260 million to create new or improved vaccines for serious respiratory diseases, such as tuberculosis (TB) and the flu. |
By Nick Paul Taylor It's decision time for Point Biopharma investors. Having dragged out the Eli Lilly buyout, investors now have phase 3 radiopharmaceutical data to compare to Novartis’ results—and days to choose whether to cash out or reject the existing offer. |
By Gabrielle Masson Against a backdrop of a tough funding environment, nearly half of biotechs are using partnerships with Big Pharmas as a financing method, according to a survey commissioned by CRO Icon. |
By Nick Paul Taylor Eli Lilly is casting a long shadow over the GLP-1 market. Structure Therapeutics linked its oral candidate to significant reductions in blood sugar and weight in a phase 2a trial on Monday, only for investors to halve the biotech's share price as they assessed the results in light of the competitive landscape. |
By Gabrielle Masson Pivotal bioVenture Partners has closed its second fund of $389 million, money that will go toward North American and European companies working to develop new therapeutics. |
By Kevin Dunleavy The FDA has signed off on Astellas and Pfizer’s Padcev in combination with Merck’s Keytruda as a first-line treatment for bladder cancer. The full endorsement, which follows an accelerated nod eight months ago, puts the combo on course to replace chemotherapy as the standard of care in locally advanced or metastatic urothelial cancer. |
By Andrea Park After racking up more than 30 years’ worth of experience in treating chronic pain, spinal cord stimulators have recently begun to expand their remit. |
By Fraiser Kansteiner Organon has unveiled a pact with Eli Lilly to take charge of Emgality and Rayvow marketing in Europe. Emgality is approved to help prevent migraines in adults who have at least four migraine days per month, while Rayvow is cleared for acute treatment of the headache phase of migraine attacks. |
By Heather Landi Kroger is piloting value-based primary care clinics as it joins a growing list of retailers looking to cash in on the booming sector of senior-focused medical care. |
By Andrea Park Even after decades of experience developing eye-related devices under its belt, Carl Zeiss Meditec is still looking to expand its ophthalmic portfolio. |
Fierce podcastsDon’t miss an episode |
| | The Fierce 50 honorees range from tech innovators to researchers developing novel therapies to providers on the frontlines of changing care. This week on "The Top Line," senior editor Paige Minemyer sat down with staff writers Dave Muoio and Anastassia Gliadkovskaya as well as senior editor Heather Landi to discuss a few of the honorees in more detail. |
|
|---|
|
|
| WhitepaperDownload this whitepaper to discover the 3 pillars of successful PK testing and conquer bioanalytical challenges. Sponsored by: Sannova Analytical |
| WhitepaperThe road to digital health innovation is exciting but complex and requires thoughtful navigation; this whitepaper serves as your guide through this process. S3 Connected Health |
| WhitepaperqPCR Assay Design - Quantify microbial biomarkers with high sensitivity and dynamic range Sponsored by: Diversigen |
| WhitepaperStreamline your clinical cell therapy with our GMP-compliant ribonucleoprotein (RNP) manufacturing as you scale up without compromising on quality to tackle complex regulatory requirements. Sponsored by: Aldevron |
| Executive SummaryBy 2030, the global demand for biologics is projected to grow at a CAGR of 8.7% and the challenges, risks, and costs of bringing large molecule products to market are growing exponentially. Sponsored by: ThermoFisher Scientific |
| WhitepaperLearn about the untapped power of AI-driven insights — where innovation meetings precision, effortlessly unlocking benefits for your organization. Sponsored by: Planisware |
| Whitepaper Medical devices & consumer wearables are starting to overlap, creating risks & opportunities for traditional medical device companies as well as consumer wearables manufacturers. This paper explores pros and cons from both perspectives. Sponsored by: Blue Matter Consulting |
| Whitepaper Improving efficiency and productivity in biologics manufacturing is a longstanding goal within today’s industry, especially now as new and increasingly complex molecules are fundamentally changing technological and operational approaches to drug development. Process intensification can help accelerate this pace of innovation through advanced process development techniques and high productivity manufacturing platforms. Sponsored by: Lonza |
| Whitepaper As a leader of technology transfer activities in the industry, Lonza understands the challenges associated with this critical step. Download this White Paper today to learn more. Sponsored by: Lonza |
| eBookEmulate in vivo biology with next-generation in vitro technology. Sponsored by: Emulate |
| |
|
